Exact Sciences Corporation (EXAS)
USD 57.38
(-4.95%)
USD 57.38
(-4.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 156.11 Million | -223.55 Million | -102.23 Million | 136.48 Million | -115.01 Million | -69.32 Million |
| Net Income | -204.14 Million | -623.5 Million | -595.62 Million | -848.53 Million | -83.99 Million | -175.14 Million |
| Depreciation & Amortization | 206.6 Million | 197.55 Million | 180.34 Million | 163.36 Million | 50.24 Million | 23.08 Million |
| Deferred income taxes | -955 Thousand | -11.9 Million | -253.16 Million | -9.86 Million | -185.1 Million | -2.78 Million |
| Stock-based compensation | 231.31 Million | 206.82 Million | 339.22 Million | 152.9 Million | 108.48 Million | 60.26 Million |
| Change in working capital | -342 Thousand | -26.37 Million | 111.1 Million | -42.72 Million | -53.55 Million | -911 Thousand |
| Other non-cash items | -76.35 Million | 33.84 Million | 202.04 Million | 721.33 Million | 48.91 Million | 26.17 Million |
| Investing Cash Flow | 49.67 Million | 74.06 Million | -1.08 Billion | -702.03 Million | -121.07 Million | -781.91 Million |
| Investments in PPE | -124.19 Million | -214.46 Million | -135.76 Million | -64.35 Million | -171.8 Million | -150.67 Million |
| Acquisitions | -68.97 Million | -57.5 Million | -517.77 Million | -22.6 Million | -973.86 Million | -17.9 Million |
| Investment purchases | -139.85 Million | -131.48 Million | -1.16 Billion | -1.08 Billion | -634.11 Million | -1.19 Billion |
| Sales/Maturities of investments | 382.95 Million | 453.07 Million | 794.32 Million | 886.67 Million | 1.66 Billion | 579.17 Million |
| Other Investing Activities | -250 Thousand | 24.45 Million | -58.81 Million | -411.8 Million | -1.85 Million | -614.29 Million |
| Financing Cash Flow | 159.76 Million | 76.48 Million | 8.47 Million | 1.87 Billion | 253.18 Million | 934.14 Million |
| Debt repayment | -137.97 Million | -50 Million | -23.74 Million | -150.05 Million | -236.12 Million | -4.81 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 28.34 Million | 25.49 Million | 23.07 Million | 18.35 Million | 8.39 Million | 4.89 Million |
| Common Stock Issuance | 31.54 Million | 6.52 Million | 37.5 Million | 861.7 Million | 17.18 Million | 4.3 Million |
| Other Financing Activities | 21.79 Million | 44.47 Million | 9.15 Million | 1.16 Billion | 17.06 Million | 1.85 Billion |
| Accounts receivables | -43.41 Million | 61.08 Million | 25.15 Million | -100.52 Million | -27.93 Million | -17.29 Million |
| Accounts payables | 82.75 Million | -52.18 Million | 153.11 Million | 46.38 Million | -645 Thousand | 11.33 Million |
| Inventory | -7.69 Million | -13.23 Million | -9.22 Million | -30.31 Million | -19.04 Million | -12.72 Million |
| Other working capital | -31.98 Million | -22.05 Million | -57.93 Million | 41.72 Million | -5.93 Million | 17.77 Million |
| Cash at beginning of period | 242.79 Million | 315.76 Million | 1.49 Billion | 177.52 Million | 160.43 Million | 77.49 Million |
| Cash at end of period | 609.67 Million | 242.79 Million | 315.76 Million | 1.49 Billion | 177.52 Million | 160.43 Million |
| Capital Expenditure | -124.19 Million | -214.46 Million | -135.76 Million | -64.35 Million | -171.8 Million | -150.67 Million |
| Effect of forex changes on cash | 1.32 Million | 30 Thousand | 23 Thousand | - | - | 36 Thousand |
| Net cash flow / Change in cash | 366.88 Million | -72.97 Million | -1.17 Billion | 1.31 Billion | 17.09 Million | 82.93 Million |
| Free Cash Flow | 31.92 Million | -438.02 Million | -238 Million | 72.13 Million | -286.81 Million | -219.99 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -38.23 Million | -15.8 Million | -110.22 Million | -204.14 Million | -49.76 Million | 794 Thousand |
| Depreciation & Amortization | 54.77 Million | 52.99 Million | 53.94 Million | 206.6 Million | 54.17 Million | 52.25 Million |
| Deferred income taxes | -398 Thousand | 428 Thousand | 1.79 Million | -955 Thousand | -676 Thousand | -951 Thousand |
| Stock-based compensation | 48.72 Million | 56.55 Million | 60.4 Million | 231.31 Million | 58.57 Million | 61.9 Million |
| Change in working capital | 78.96 Million | 29.24 Million | -108.2 Million | -342 Thousand | 26.65 Million | -24.57 Million |
| Other non-cash items | -5.11 Million | 132.75 Million | 13.15 Million | -76.35 Million | -19.41 Million | -65.03 Million |
| Investing Cash Flow | -81.71 Million | -147.12 Million | -171.43 Million | 49.67 Million | -66.76 Million | -32.96 Million |
| Investments in PPE | -26.15 Million | -35.86 Million | -37.64 Million | -124.19 Million | -34.92 Million | -25.18 Million |
| Acquisitions | -44.76 Million | - | -237 Thousand | -68.97 Million | -21.98 Million | -40.82 Million |
| Investment purchases | -81.35 Million | -147.62 Million | -177.32 Million | -139.85 Million | -64.75 Million | -24.44 Million |
| Sales/Maturities of investments | 70.58 Million | 36.35 Million | 43.97 Million | 382.95 Million | 54.89 Million | 57.22 Million |
| Other Investing Activities | -20 Thousand | -111.26 Million | -205 Thousand | -250 Thousand | 500 Thousand | 250 Thousand |
| Financing Cash Flow | -226 Thousand | 224.6 Million | -3 Million | 159.76 Million | 10.03 Million | 92 Thousand |
| Debt repayment | -266.75 Million | -266.75 Million | - | -137.97 Million | -137.97 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 20.76 Million | -1.36 Million | - | 28.34 Million | 28.34 Million | - |
| Common Stock Issuance | -19.4 Million | 19.4 Million | - | 31.54 Million | -109.32 Million | 1.07 Million |
| Other Financing Activities | 265.15 Million | -61.54 Million | -1.59 Million | 21.79 Million | 10.03 Million | 92 Thousand |
| Accounts receivables | -509 Thousand | -23.36 Million | -37.53 Million | -43.41 Million | -3.11 Million | -19.81 Million |
| Accounts payables | 56.12 Million | 35.65 Million | -53.51 Million | 82.75 Million | 31.66 Million | 2.33 Million |
| Inventory | -9.61 Million | 1.16 Million | -1.06 Million | -7.69 Million | 5.38 Million | -543 Thousand |
| Other working capital | 297 Thousand | 15.79 Million | -16.09 Million | -31.98 Million | -7.28 Million | -6.54 Million |
| Cash at beginning of period | 530.17 Million | 347.48 Million | 609.67 Million | 242.79 Million | 594.9 Million | 604.66 Million |
| Cash at end of period | 594.66 Million | 530.17 Million | 351.78 Million | 609.67 Million | 609.67 Million | 594.9 Million |
| Capital Expenditure | -26.15 Million | -35.86 Million | -37.64 Million | -124.19 Million | -34.92 Million | -25.18 Million |
| Effect of forex changes on cash | 1.87 Million | -306 Thousand | -1.14 Million | 1.32 Million | 1.94 Million | -1.23 Million |
| Net cash flow / Change in cash | 64.48 Million | 182.69 Million | -257.89 Million | 366.88 Million | 14.76 Million | -9.75 Million |
| Free Cash Flow | 112.56 Million | 71.19 Million | -119.96 Million | 31.92 Million | 34.62 Million | -826 Thousand |
MSNVF
MRNO
002643
RVU
FCX
603083